Arzneimittel-Kompass 2022 2022
DOI: 10.1007/978-3-662-66041-6_4
|View full text |Cite
|
Sign up to set email alerts
|

Potenziell inadäquate Medikation für ältere Menschen – PRISCUS 2.0

Abstract: PRISCUS und PRISCUS 2.0: Potenziell inadäquate Medikation für den deutschen Arzneimittelmarkt -53 4.3 Datengrundlage und Methoden -54 4.4 PRISCUS-2.0-Arzneistoffe -55 4.5 Ergebnisse -56 4.5.1 Verordnungen von PRISCUS-Medikamenten -58 4.5.2 Verordnungen von PRISCUS-2.0-Medikamenten nach Alter und Geschlecht -58 4.5.3 Verordnungen von PRISCUS-2.0-Medikamenten nach Wirkstoffen -61 4.5.4Verordnungen von PRISCUS-2.0-Medikamenten nach Facharztgruppen -64 4.5.5Verordnungen von PRISCUS-2.0-Medikamenten ausgewählter Wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 51 publications
0
3
0
1
Order By: Relevance
“…With increasing age, item inter-correlations, especially for the “inner resilience and coherence subscale” (subscale 1), dissolved. Reasons for lower correlations are the prospect of a shorter remaining lifespan, combined with simultaneously experiencing multimorbidity and functional limitations, which can lead to the use of polypharmacy [ 4 ] and prolonged addictive medication [ 5 ]. In a recent study, polypharmacy has been found to be strongly associated with disease burden in geriatric individuals [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…With increasing age, item inter-correlations, especially for the “inner resilience and coherence subscale” (subscale 1), dissolved. Reasons for lower correlations are the prospect of a shorter remaining lifespan, combined with simultaneously experiencing multimorbidity and functional limitations, which can lead to the use of polypharmacy [ 4 ] and prolonged addictive medication [ 5 ]. In a recent study, polypharmacy has been found to be strongly associated with disease burden in geriatric individuals [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, as life expectancy increases, older people suffer longer or later in life from chronic somatic conditions (e.g., coronary heart disease, Diabetes Mellitus Type 2 and/or cancer), co- and multimorbidity and functional limitations [ 3 ]. Recent studies among the elderly show that multimorbidity in this population increases the risk of polypharmacy [ 4 ], the use of addictive medication such as neuroleptics and benzodiazepine [ 5 ], and the likelihood to experience depression [ 6 , 7 ], anxiety and stress [ 8 ]. Additionally, multimorbidity can lead to feelings of elevated interpersonal dependency [ 9 ] and poor health-related quality of life (HRQL) [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…Diese ist auch im Internet (www.medikamente-im-alter.de) oder als App (FORTA) verfügbar. Eine weitere Option ist die PRISCUS-Liste (www.priscus2-0.de) potentiell inadäquater Medikamente (PIM) [10]. Besonders kritisch gerade aus orthopädischunfallchirurgischer Sicht sind dabei die sogenannten Fall risk increasing Drugs (FRID) [8].…”
Section: Polypharmazieunclassified
“…This appears particularly important because of their high impact on practice and ability to reduce the number of PIMs prescribed. [11][12][13] Overall, the respondents were very positive how the information was presented to them. Nevertheless, there still seems to be room for improvement.…”
mentioning
confidence: 95%